1 / 45

Clinical Management Respiratory Diseases

Clinical Management Respiratory Diseases. Judith Coombes University of Queensland Brisbane, Australia. Pathology. major international cause of morbidity and mortality In Australia single biggest cause of days lost from work generate largest number of GP visits. Objectives.

daniel_millan
Télécharger la présentation

Clinical Management Respiratory Diseases

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Management Respiratory Diseases Judith Coombes University of Queensland Brisbane, Australia

  2. Pathology major international cause of morbidity and mortality In Australia single biggest cause of days lost from work generate largest number of GP visits Judith Coombes UQ and PAH

  3. Objectives Be able to interpret Spirometry as a lung function test and monitoring tool Be able to interpret Peake Expiratory Flow rate (PEFR) as a monitoring tool Understand goals of treatment and be able to communicate pharmaceutical care plan in asthma Understand goals of treatment of and be able to communicate pharmaceutical care plan in COPD Not discussing infections, neoplasms or TB

  4. The Lungs Trachea Bronchus(L&R) Bronchi Bronchiole Alveoli Trachea

  5. Respiratory Symptoms cough sputum production/haemoptysis dyspnoea wheezing chest/lung pain

  6. Measurement of ventilatory function Spirometry PEFR Blood Gas Exercise test-6 min chest Xray- normal is asthma and COPD

  7. Spirometry Spirometer FVC = Forced Vital Capacity FEV1= Forced Expiratory Volume over 1 second FEV1/FVC is forced expiratory ratio should be >75% useful for diagnosis accurately measures degree of impairment

  8. Normal

  9. PEFR Peak Flow Meter maximum flow rate which can be forced during an expiration may differ between meters Submaximal effort invalidates reading Not a substitute for spirometry most useful for regular monitoring to detect variation warning signs sustained reduction >20-25% diurnal variation monitoring

  10. Chest X ray Diagnosis is uncertain (PE, pneumonia, heart failure) symptoms may not be explained by asthma or COPD physical evidence of complications-pneumothorax, atelectasis (lung collapse) failure to respond to treatment

  11. Blood Gas (arterial) H+ rises with Pco2 In acute hypoventilation CO2 rises and so does H+ causing respiratory acidosis In acute hyperventilation CO2 drops as does H+ causing respiratory alkalosis (in acute no time for metabolic process so bicarbonate is not changed)

  12. Oximetry Measure oxygen saturation Non invasive Light emiting diodes Expressed as % where normal is 100%

  13. Asthma a chronic inflammatory disorder of the airways in which many cells and cellular elements play a role, in particular, mast cells, eosinophils, T lymphocytes, macrophages, neutrophils and epithelial cells. In susceptible individuals this inflammation causes recurrent episodes of wheezing, breathlessness, chest tightness and coughing, particularly, at night or in the early morning. These episodes are usually associated with widespread but variable airflow obstruction that is often reversible either spontaneously or with treatment. The inflammation also causes an associated increase in the existing bronchial hyperresponsiveness to a variety of stimuli. USA97

  14. Airflow obstruction (Excessive airway Narrowing) Smooth muscle hypertrophy and hyperplasia Inflammatory cell infiltration Oedema Goblet cell and mucous gland hyperplasia Mucus hypersecretion Protein deposition Epithelial desquamation

  15. Asthma Diagnosis-1 No Gold Standard Consensus of respiratory physicians History, physical examination, supportive diagnostic testing History Wheeze Chest tightness Shortness of breath cough

  16. Asthma Diagnosis-2 • Physical examination • Expiratory wheeze suggests asthma (not pathonomonic) • Absence of physical signs doesn’t exclude asthma • Crackles indicate concurrent or alternate diagnosis

  17. Asthma diagnosis -3 • Diagnostic testing –Spirometry • Pay Attention to technique • Pre and post bronchodilator • Baseline FEV1>1.7L and increase of 12% post bronchodilator is significant • Or 200ml greater than baseline • Or same rules for FVC • Also % predicted from tables in the Asthma guidelines

  18. Spirometry for asthma management Assessment of severity Severe acute attack <50% predicted or < 1litre Back titration of medication Check symptomatic assessment Maintain best lung function

  19. Asthma

  20. PEFR with asthma Diagnosis-not a substitute for spirometry PEF increases >15% with bronchodilator PEF in adult varies >20% for 3 days in a week over several weeks Severe Acute <50% predicted or < 100 L/min Useful for daily home measurement Useful in action plan >80% OK, 60-80% increase preventer, 40-60% oral steroids, <40% no relief 000

  21. Asthma treatment National Asthma Council in Australia • www.nationalasthma.org.au/cms/index.php • Reduce mortality &morbidity of asthma • Education • Patient self monitoring • Appropriate drug therapy • Regular medical review • Written asthma action plan

  22. Asthma management • Acute asthma management • Treatment depends on severity • Mild, moderate, life threatening • Requires emergency care • Hospital admission • Long term asthma management-chronic • Minimise symptoms and need for reliever • No exacerbations • No limitation on physical activity • Normal Lung Function

  23. Asthma Management • Medications to treat bronchospasm • ACUTE • RELEIVERS • Short acting ß2-adrenergic agonists eg salbutamol terbutaline • Anticholinergic eg ipratropium

  24. Relievers

  25. Asthma Management • Medications to treat bronchospasm • Chronic • SYMPTOM CONTROLLER • Inhaled long acting ß2-adrenergic agonists eg salmeterol • Also use • Theophylline • Oral ß2-adrenergic agonists (salbutamol syrup)

  26. Asthma Management • Medications to treat inflamation PREVENTERS Inhaled sodium cromoglycate Inhaled nedocromil sodium Inhaled cortocosteroids eg beclomethasone Oral corticosteroids eg prednisolone Leukotrienne receptor antagonists eg montelukast

  27. Beclomethasone dipropionate

  28. Asthma Action plans • Developed by doctor with patient • Added role for pharmacist to give advice to patient • Individualised Action for Deterioration in asthma • ↑ in frequency, severity of symptoms • ↑ use of bronchdilator • Drop in peak flow

  29. Misuse of Home Nebulizers High Among Inner-City Children with Asthma October 25, 2006 (Salt Lake City) A study of asthma-related deaths among inner-city children and young adults shows that only about half use their home nebulizers as prescribed and rarely have an asthma action plan to manage disease exacerbations, or if they do have a written plan in the home, they rarely use it. The findings were presented here yesterday at CHEST 2006, the 72nd annual meeting of the American College of Chest Physicians.

  30. COPD smoking is major cause but susceptibility is variable directly related to exposure to tobacco smoke pack years=cigarettes/day x years of smoking /20 relatively fixed airway obstruction with minimal reversibility from bronchodilators

  31. COPD Chronic bronchitis- productive cough for >3 months in 2 successive years emphysema-abnormal permanent enlargement of air-spaces distal to terminal bronchioles caused by destruction of alveolar walls. Most have a combination of both Elderly with reversibility has all 3

  32. COPD = shaded bit

  33. Diagnosis of COPD symptoms breathlessness doesn’t occur until obstruction is advanced (unless intercurrent infection) physical examination little until disease is severe-over inflated chest chest x rays over inflation, enlarged heart, bullae spirometry mild check FEV1/FVC<75% moderate check FEV1 % of predicted

  34. COPD

  35. Show ceases smoking figure

  36. Progression

  37. COPD Management • Acute exacerbations • Bronchodilators • Oxygen • Corticosteroids • Antibiotics • Long term treatment- chronic • Stop smoking • Bronchodilators • Corticosteroids • Immunisation-Pneumonia and flu • Pulmonary rehabilitation

  38. Bronchiectasis defined as dilation of the bronchi- bronchial walls become inflamed, thickened and irreversibly damaged. Mucociliary transport is impaired-bacterial infections cough productive of sputum

  39. Cystic Fibrosis dysfunction of exocrine glands -abnormal mucus production recurrent bronchopulmonary infection finger clubbing haemoptysis

  40. Interstitial lung disease heterogeneous group involving alveolar walls and peri alveolar tissue insidious onset, chronic disease inflammatory process probably initiated by an antigen eventual interstitial fibrosis will cause a restrictive pattern

  41. Restrictive

  42. Severe Obstructive Sleep Apnoea 2% women , 4% men Recurrent episodes of airway occlusion in sleep Apnoea Arousal Daytime sleepiness Increased CO2 Sleep lab Weight loss, CPAP

More Related